Status:
COMPLETED
Transcranial Static Magnetic Field Stimulation of Frontal Cortex
Lead Sponsor:
University of North Carolina, Chapel Hill
Conditions:
Healthy
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The purpose of this study is to see if a new brain stimulation technique, static magnetic field stimulation (tSMS), which involves holding a static neodymium magnet over the scalp, can influence norma...
Detailed Description
The investigator's primary objective is to determine the feasibility of modifying frontal brain activity using static magnetic fields. The investigator's will be examining the effects of static magnet...
Eligibility Criteria
Inclusion
- Right-handed, healthy, 18+ years old
- Capacity to understand all relevant risks and potential benefits of the study (informed consent)
- Willing to comply with all study procedures and be available for the duration of the study - Speak and understand English
Exclusion
- Medical history of Psychological/Emotional Disorders (depression, anxiety, bipolar, etc.)
- (For females) Pregnancy or breast feeding
- Diagnosis of eating disorder (current or within the past 6 months)
- Diagnosis of Obsessive-Compulsive Disorder (lifetime) Attention Deficit Hyperactivity Disorder (currently under treatment)
- Neurological disorders and conditions, including, but not limited to:
- History of epilepsy
- Seizures (except childhood febrile seizures and Electroconvulsive therapy-induced seizures)
- Dementia
- History of stroke
- Parkinson's disease
- Multiple sclerosis
- Cerebral aneurysm
- Brain tumors
- Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment)
- Prior brain surgery Any brain devices/implants, including cochlear implants and aneurysm clips
- Any metal in/on the body, e.g., dental braces, glasses, piercings
- Traumatic brain injury
- Thick hair that would create distance between the magnet and the scalp
- Taking hormonal birth control or hormonal supplements (e.g., testosterone injections) - Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study
Key Trial Info
Start Date :
August 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2017
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03244501
Start Date
August 8 2017
End Date
September 15 2017
Last Update
October 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNC Chapel Hill
Chapel Hill, North Carolina, United States, 27514